HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Liver transplant for metastatic neuroendocrine tumor.

Abstract
Generally, the results of liver transplantation for metastatic liver disease have not been favorable. One exception has been the unique group of neuroendocrine tumors, the slow growth of which allows liver transplantation to effectively palliate and control symptoms. We report two cases: (a) A 51-year-old man who underwent orthotopic liver transplantation and resection of the pancreatic primary tumor for a nonfunctioning malignant neuroendocrine tumor with features of both carcinoid and islet-cell glucagonoma remains symptom-free and without evidence of tumor recurrence at 13 months follow-up. (b) A 47-year-old man who underwent orthotopic liver transplantation and Whipple resection for a metastatic islet-cell tumor in the head of the pancreas is fully recovered at 5 months follow-up.
AuthorsA E Alsina, S Bartus, D Hull, R Rosson, R T Schweizer
JournalJournal of clinical gastroenterology (J Clin Gastroenterol) Vol. 12 Issue 5 Pg. 533-7 (Oct 1990) ISSN: 0192-0790 [Print] United States
PMID1699994 (Publication Type: Case Reports, Journal Article, Review)
Topics
  • Humans
  • Liver Neoplasms (secondary, surgery)
  • Liver Transplantation
  • Male
  • Middle Aged
  • Neoplasms, Glandular and Epithelial (secondary, surgery)
  • Palliative Care
  • Pancreatic Neoplasms (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: